Avasimibe inhibits ACAT with IC50 of 3.3 μM, also inhibits human P450 isoenzymes CYP2C9, CYP1A2 and CYP2C19 with IC50 of 2.9 μM, 13.9 μM and 26.5 μM, respectively.A cholesterol reducing compound that also inhibits CYP.
Specifications and Purity: ≥98%
MDL Number: MFCD00934956
Molecular Formula: C29H43NO4S
Molecular Weight: 501.72
PubChem CID: 166558
Isomeric SMILES: CC(C)C1=C(C(=CC=C1)C(C)C)OS(=O)(=O)NC(=O)CC2=C(C=C(C=C2C(C)C)C(C)C)C(C)C
Related Documents: https://aladdin-for-icloud-store.oss-cn-hangzhou.aliyuncs.com/aladdinsci/pdp/sds/1/A129742-SCI_2eb4a9cfd869cb71fb0e86a280f3f147.pdf
- UPC:
- 51201624
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- A129742-50mg
- CAS:
- 166518-60-1
- Product Size:
- 50mg
akash.verma@cenmed.com
(732) 447-1115





